I also have done an extensive search and am also a subscriber to Bloomberg premium content and can confirm there is not and has not been any mention of an investor roadshow, it does seem someone with alterior motives has made it up.
We remain one of only a few companies worldwide that has the capability to produce high affinity, humanised anti-glycan antibodies and continue to evaluate options and potential agreements for the Company's GlyMab® antibodies in order to provide further third-party validation, develop the business and generate revenues.”
Any company can offer any amount to buy scancell, and if they make a formal offer then it will be put to a shareholder vote, LD may say it’s too low but she can’t stop it.